Document Detail

Ursodeoxycholic acid for primary biliary cirrhosis.
MedLine Citation:
PMID:  10563063     Owner:  NLM     Status:  MEDLINE    
Primary biliary cirrhosis is a progressive chronic liver disease estimated to affect up to 1 in 4000 people in the UK. Patients with end-stage disease or an associated poor quality of life commonly need a liver transplant. Traditionally, drugs have offered little help as their benefits are modest and their unwanted effects unacceptable. Recently, the bile acid ursodeoxycholic acid has been used to treat primary biliary cirrhosis. Here we discuss the place of such therapy.
Related Documents :
25337243 - Identification of hepatitis b virus x gene variants between hepatocellular carcinoma ti...
8876623 - Concentration of unsulfated lithocholic acid in portal and systemic venous plasma: evid...
10412903 - Identification of senescence-associated genes from daylily petals.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Drug and therapeutics bulletin     Volume:  37     ISSN:  0012-6543     ISO Abbreviation:  Drug Ther Bull     Publication Date:  1999 Apr 
Date Detail:
Created Date:  1999-11-30     Completed Date:  1999-11-30     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0112037     Medline TA:  Drug Ther Bull     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  30-2     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholagogues and Choleretics / therapeutic use*
Liver Cirrhosis, Biliary / drug therapy*
Randomized Controlled Trials as Topic
Ursodeoxycholic Acid / therapeutic use*
Reg. No./Substance:
0/Cholagogues and Choleretics; 128-13-2/Ursodeoxycholic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The challenge of the Internet.
Next Document:  International multicentre comparison of cerivastatin with placebo and simvastatin for the treatment ...